Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Milbemycin Oxime. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105440049B reveals a scalable oxidation method for high-purity milbemycin oxime, offering significant cost reduction and supply chain reliability for veterinary drug manufacturers.
Patent CN105949217A reveals TEMPO oxidation for milbemycin oxime intermediate. Offers high purity, cost reduction in pharmaceutical intermediates manufacturing, and scalable supply.